Perspective Therapeutics, Inc. Net Income Loss

• Perspective Therapeutics, Inc. showed a decrease of -30.1% in Net Income Loss from 2024 to 2025.
• This data is from Perspective Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
• XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 15 years of available data (2012 to 2025), Perspective Therapeutics, Inc.'s Net Income Loss has declined by 2,855.7%.
• Historical annual values: Fiscal year 2025: -$103.12 million | Fiscal year 2024: -$79.28 million | Fiscal year 2023: -$46.51 million | Fiscal year 2022: -$10.76 million | Fiscal year 2022: -$7.27 million | Fiscal year 2021: -$3.39 million | Fiscal year 2020: -$3.45 million | Fiscal year 2019: -$5.14 million | Fiscal year 2018: -$6.70 million | Fiscal year 2017: -$6.16 million | Fiscal year 2016: -$4.71 million | Fiscal year 2015: -$3.68 million | Fiscal year 2014: -$5.96 million | Fiscal year 2013: -$3.86 million | Fiscal year 2012: -$3.49 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026